
Opinion|Videos|June 24, 2024
Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Annual ACS NCDB report details national trends in prostate cancer care
2
Treatment Selection in Advanced Prostate Cancer
3
FDA provides guidance on development pathway for testosterone therapy for women
4
Strategic Use of ADT in mCSPC From Selection to Escalation
5








